Ropeginterferon alfa-2b (Besremi)
- Status:
- Red
- Decision Date:
- July 2020
Comments
Monotherapy of polycythaemia vera without
symptomatic splenomegaly in adults. Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again